These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3196378

  • 1. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H, Smith BA, Lefer AM.
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [Abstract] [Full Text] [Related]

  • 2. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
    Hock CE, Lefer DJ, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
    [Abstract] [Full Text] [Related]

  • 3. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
    Karasawa A, Rochester JA, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of two leukotriene antagonists in rat traumatic shock.
    Levitt MA, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
    [Abstract] [Full Text] [Related]

  • 5. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N, Johnson G, Siegfried MR, Lefer AM.
    Eicosanoids; 1989 May; 2(3):169-74. PubMed ID: 2534278
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE, Lefer AM.
    Circ Shock; 1985 May; 17(4):263-72. PubMed ID: 3841503
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
    Hock CE, Lefer AM.
    Circ Shock; 1984 May; 14(3):159-68. PubMed ID: 6542462
    [Abstract] [Full Text] [Related]

  • 8. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H, Smith BA, Lefer AM.
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [Abstract] [Full Text] [Related]

  • 9. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A, Rochester JA, Lefer AM.
    Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
    [Abstract] [Full Text] [Related]

  • 10. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
    Kitzen JM, Lynch JJ, Driscoll EM, Lucchesi BR.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock.
    Skurk C, Nuss C, Lefer AM.
    Shock; 1995 Jan; 3(1):13-20. PubMed ID: 7531603
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
    Levitt MA, Lefer AM.
    Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
    [Abstract] [Full Text] [Related]

  • 13. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA, Lefer AM.
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
    [Abstract] [Full Text] [Related]

  • 14. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
    Bitterman H, Lefer DJ, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
    [Abstract] [Full Text] [Related]

  • 15. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE, Su JY, Lefer AM.
    Circ Shock; 1983 Jun; 11(3):211-6. PubMed ID: 6652878
    [Abstract] [Full Text] [Related]

  • 16. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
    Bitterman H, Smith BA, Lefer DJ, Lefer AM.
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):293-9. PubMed ID: 2464101
    [Abstract] [Full Text] [Related]

  • 17. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H, Stahl GL, Lefer AM.
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [Abstract] [Full Text] [Related]

  • 18. Protective actions of nafazatrom in traumatic shock.
    Lefer AM, Messenger M.
    Arzneimittelforschung; 1982 Jan; 32(9):1089-91. PubMed ID: 6890831
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
    Levitt MA, Stahl G, Lefer AM.
    Resuscitation; 1988 Jul; 16(3):211-20. PubMed ID: 2845544
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
    Narimatsu A, Kitada Y, Satoh N, Suzuki R, Okushima H.
    Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.